AdvancedSelf-pacedNo New Dates

Psychoactive Pharmaceutical Investigation

The Psychoactive Pharmaceutical Investigation Master’s program at the University of Wisconsin-Madison is a program that trains students to become leaders in the rapidly expanding field of psychoactive pharmaceutical research.

Details

12 months
12 modules

Enrollment

$1,500
This course is currently marked as no new dates.

Course Overview

The Psychoactive Pharmaceutical Investigation Master's program at the University of Wisconsin–Madison is an online program designed to train leaders in the field of psychoactive pharmaceutical research. The curriculum integrates chemistry and culture, equity and ethnobotany, and phenomenology and pharmacokinetics. Students gain mastery in unique pharmacologic and physiologic considerations for CNS drug development, laws, regulations, and ethical principles. The program also covers historical pressures and cutting-edge discoveries in psychedelic and cannabinoid research. The program confers a Master of Science in Pharmaceutical Sciences and requires 30 graduate credits. Completion time ranges from 12 months to three years depending on credit load per semester.

Who is this for?

Students interested in psychoactive pharmaceutical research, including those preparing for work in psychedelic and cannabinoid development, regulation, and related scientific fields.

About the Provider

The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances is dedicated to exploring the scientific, historical, and cultural aspects of psychoactive substances, focusing on psychedelics.

View University of Wisconsin-Madison profile

Course Details

  • Price$1,500
  • FormatSelf-paced
  • Lifecycle statusNo New Dates
  • Skills
    pharmacologic considerationsphysiologic considerationsCNS drug developmentdrug delivery projectslaws and regulationsethical principleshistorical pressurescurrent challengescutting-edge discoveriespsychedelic researchcannabinoid researchregulatory frameworksPsychedelic and cannabinoid researchDrug delivery considerations
  • Categories